Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Online life sciences mapping tool launched

UK opens up database of 5,000 life science companies and sites
UK_Life_Sciences_map

Details of 5,000 UK life science companies and sites have been put online in a new online mapping tool from the government.

Put together by the UK Trade & Investment (UKTI) department, the site - which covers the pharma, biotech and med tech sectors - is intended to help the industry identify potential collaborators, suppliers and customers.

Companies can be searched for on the basis on sector, product group and location and the site has also plugged in some social media details of the companies featured in the database.

The information included in the UK Life Sciences website comes from the the Bioscience and Health Technology Database which is owned by the Office for Life Sciences within the Department for Business, Innovation and Skills.

Meanwhile, UKTI told the BIA that it had sourced the turnover and employment information featured “from a third party on a commercial basis”, in addition to drawing from reported figures or estimated figures.

“No confidential information has been included in the website but there is the option for companies to opt-out if they prefer,” UKTI added.

Steve Bates, CEO of the BioIndustry Association, said: “The BIA has long advocated that enabling global partners to better see the strength and opportunity within companies in the UK life science ecosystem should be core to UKTI's life science mission and we hope that this new initiative can play a key role.”

21st November 2014

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...